Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
56,222,082
-
Total 13F shares
-
46,978,082
-
Share change
-
-910,359
-
Total reported value
-
$12,435,000,841
-
Put/Call ratio
-
119%
-
Price per share
-
$264.84
-
Number of holders
-
481
-
Value change
-
-$247,603,948
-
Number of buys
-
200
-
Number of sells
-
226
Institutional Holders of REPLIGEN CORP - COMMON STOCK (RGEN) as of Q4 2021
As of 31 Dec 2021,
REPLIGEN CORP - COMMON STOCK (RGEN) was held by
481 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
46,978,082 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, Invesco Ltd., WCM INVESTMENT MANAGEMENT, LLC, STATE STREET CORP, FRED ALGER MANAGEMENT, LLC, AMERIPRISE FINANCIAL INC, FRANKLIN RESOURCES INC, and ALLIANCEBERNSTEIN L.P..
This page lists
484
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.